학술논문

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Document Type
Article
Source
Pharmacological Reports; Dec2022, Vol. 74 Issue 6, p1279-1285, 7p
Subject
Language
ISSN
17341140